Photobiomodulation on Core Symptoms of Autism

Sponsor
Suez University
Study ID
NCT07542899
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - 6 Years
Healthy Volunteers
Not accepted

Interventions

  • Photobiomodulation — DEVICE
    non-invasive exposure of light, typically within the red to near-infrared (\~λ = 600-1300 nm) spectrum, to elicit physiological effects across several tissue systems. The application will be transcranial with distance of 50 cm above the head. The child is in supine lying position with eyes covered with sheet

Study Details

This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.

Key Dates

First listed
Apr 21, 2026
Start date
Apr 10, 2026
Status verified
Apr 2026
Primary completion
Jul 10, 2026
Completion
Aug 10, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Photobiomodulation Group
  • No Intervention: control group

Primary Outcome Measure

Improvement in core symptoms of autism [ Time Frame: Baseline and after 3 months of intervention ]

Central Contacts

Find similar trials

Nationwide
Autism spectrum disorder trialsPediatrics trials

Related Studies